VC

Valliance Capital

North America, California, United States, San Francisco

Description

Valliance Capital is an investment management firm.

Investor Profile

Valliance Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (50%)
  • Private Equity (50%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Medical
  • Biotechnology
  • Health Care
  • Medical Device
  • Apps
  • Delivery
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Valliance Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
FountainVest Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
SC
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
TPG Capital Asia
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Redview Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Orchid Asia Group Management
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 1

What are some of recent deals done by Valliance Capital?

Dingdang Kuaiyao

Beijing, Beijing, China

Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform.

AppsDeliveryE-CommerceMedical
Private EquityJun 8, 2021
Amount Raised: $220,000,000
Broncus Technologies

Mountain View, California, United States

Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.

BiotechnologyHealth CareMedicalMedical Device
Series DJan 28, 2021